Rigel Pharmaceuticals: Q4 Earnings Insights

Rigel Pharmaceuticals RIGL reported its Q4 earnings results on Tuesday, March 5, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Rigel Pharmaceuticals beat estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.03.

Revenue was down $15.49 million from the same period last year.

Last quarter the company beat on EPS by $0.04 which was followed by a 2.0% increase in the share price the next day.

Here's a look at Rigel Pharmaceuticals's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.07	-0.08	-0.10	-0.11
EPS Actual	-0.03	-0.04	-0.08	0.01
Revenue Estimate	27.20M	26.02M	24.07M	27.97M
Revenue Actual	28.13M	26.89M	26.07M	51.28M

To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar